Improvements in vaccination

Details for Australian Patent Application No. 2004271726 (hide)

Owner Glaxo Group Limited

Inventors Craigen, Jennifer L; Bembridge, Gary Peter

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004271726

PCT Pub. Number WO2005/025614

Priority 0321615.7 15.09.03 GB

Filing date 13 September 2004

Wipo publication date 24 March 2005

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025614 Priority application(s): WO2005/025614

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271730-Combination of a histone deacetylase inhibitor with a death receptor ligand

2004271725-The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases